Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid treatment increases a specific acid in urine by blocking an enzyme, possibly causing skin rash and hair loss.

Vitamin D Dependent Rickets Type-2A can cause complete hair loss and bone growth issues in infants.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Valproic acid can cause muscle damage and liver issues, which improve after stopping the drug.

A child with a rare type of rickets showed some improvement with high doses of vitamin D, but such conditions often respond poorly to treatment.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Ayurvedic treatment improved Vitamin B12 levels and symptoms.

Intravenous and oral calcium effectively treated vitamin D dependent rickets type II, improving growth and bone health.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

Vitamin D supplements should be used cautiously in sarcoidosis patients, with regular monitoring to avoid high calcium levels.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

Amra Beej Majja Churna may help improve Vitamin B12 levels and symptoms in vegans.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Mice without the vitamin D receptor are more prone to UV-induced skin tumors.

Knuckle darkening can be an early sign of vitamin B12 deficiency.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Karaviradya taila reduces hair growth and hair follicles.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Ruxolitinib can cause a delayed skin reaction on the nose.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Bakuchi therapy significantly improved psoriasis symptoms.